Company News

L’Oréal’s New Research Looks at Impact of Pigmentation, Hormonal Variations on Women’s Skin & Scalp

La Roche-Posay and Vichy unveil research at the World Congress of Dermatology in Singapore.

Author Image

By: Christine Esposito

Editor-in-Chief

At the World Congress of Dermatology (WCD) in Singapore, L’Oréal unveiled new research and innovations for skin health. L’Oréal Dermatological Beauty (LDB) unveiled the results of two global skin health studies conducted by La Roche-Posay (LRP) and Vichy, respectively: • In the largest study of its kind, LRP surveyed 48,000 people across 34 countries and found that half (50%) suffer from self-reported pigmentary disorders (PD) including vitiligo, post-inflammatory hyperpigmentation and mel...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters